XTL Biopharmaceuticals Ltd. (XTLB)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Statements of Financial Position | — |
|
| Consolidated Statements of Financial Position (P) | — |
|
| Consolidated Statements of Comprehensive Income (loss) | — |
|
| Consolidated Statements of Comprehensive Loss | — |
|
| Consolidated Statements of Changes In Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Accounts Payable | — |
|
| Basis of Preparation | — |
|
| Cash and Cash Equivalents | — |
|
| Commitments and Contingent Liabilities | — |
|
| Convertible Loan From Shareholder | — |
|
| Cost of Service | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Discontinued Operations | — |
|
| Earnings (loss) Per Share | — |
|
| Finance Income (expenses), Net | — |
|
| Financial Instruments and Financial Risk Management | — |
|
| General | — |
|
| General and Administrative Expenses | — |
|
| Insider Trading Arrangements | — |
|
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Loans and Credit From Banking Corporations | — |
|
| Loss Per Share | — |
|
| Marketable Securities Intercure Ltd | — |
|
| Material Accounting Policies | — |
|
| Prepaid Expenses and Othe Current Assets | — |
|
| Prepaid Expenses and Other Current Assets | — |
|
| Profit (loss) Per Share | — |
|
| Research and Development Expenses | — |
|
| Revenues | — |
|
| Revenues and Cost of Services | — |
|
| Sales and Marketing Expenses | — |
|
| Segment Reporting | — |
|
| Share Capital, Reserves and Accumulated Deficit | — |
|
| Share-based Payment | — |
|
| Subsequent Events | — |
|
| Subsidiaries | — |
|
| Taxes On Income | — |
|
| Transactions and Balances With Related Parties | — |
|
| Warrants | — |
|